VAS
TWST icon

Vestmark Advisory Solutions’s Twist Bioscience TWST Stock Holding History

Vestmark Advisory Solutions’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.76M Sell
85,142
-24,124
-22% -$1.57M 0.08% 257
2026
Q1 		$5.19M Sell
109,266
-20,724
-16% -$929K 0.06% 343
2025
Q4 		$4.12M Buy
129,990
+12,741
+11% +$398K 0.06% 348
2025
Q3 		$3.3M Sell
117,249
-80,348
-41% -$2.43M 0.06% 315
2025
Q2 		$7.27M Buy
197,597
+106,541
+117% +$3.68M 0.11% 149
2025
Q1 		$3.57M Sell
91,056
-11,872
-12% -$535K 0.09% 252
2024
Q4 		$4.5M Buy
102,928
+40,189
+64% +$1.82M 0.15% 145
2024
Q3 		$2.83M Sell
62,739
-18,054
-22% -$859K 0.11% 210
2024
Q2 		$3.98M Sell
80,793
-33,588
-29% -$1.37M 0.17% 138
2024
Q1 		$3.92M Sell
114,381
-9,066
-7% -$327K 0.17% 141
2023
Q4 		$4.55M Buy
+123,447
New +$2.85M 0.23% 105

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vestmark Advisory Solutions's TWST Position: Q2 2026 in Review

Vestmark Advisory Solutions reduced its Twist Bioscience (TWST) stake by 22% in Q2 2026, selling an estimated $1.57M and leaving 85,142 shares worth $8.76M. The position accounts for 0.08% of the portfolio, ranked #257.

Vestmark Advisory Solutions first reported a position in TWST in Q4 2023 and has held it in 11 quarters since. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Vestmark Advisory Solutions held 85,142 shares of Twist Bioscience worth $8.76M as of Q2 2026.
  • Vestmark Advisory Solutions sold 24,124 Twist Bioscience shares in Q2 2026, an estimated $1.57M.
  • Twist Bioscience made up 0.08% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #257 holding.
  • Vestmark Advisory Solutions first reported a position in Twist Bioscience in Q4 2023 and has held it in 11 quarters since.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.